Survey of advanced radiation technologies used at designated cancer care hospitals in Japan

Japanese Journal of Clinical Oncology

Volumn 44, Issue 1, 2014, Pages 72-77

  Shikama, Naoto ^a   Tsujino, Kayoko ^b   Nakamura, Katsumasa ^c   Ishikura, Satoshi ^d  

^a SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^b HYOGO CANCER CENTER   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced radiotherapy technology; Intensity modulated radiotherapy; Radiotherapy; Stereotactic body radiotherapy

Indexed keywords

ARTICLE; CANCER CENTER; CANCER RADIOTHERAPY; CORRELATION ANALYSIS; HEAD AND NECK CANCER; HEALTH CARE QUALITY; HEALTH CARE SURVEY; HOSPITAL PERSONNEL MANAGEMENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; JAPAN; LINEAR ACCELERATOR; LUNG CANCER; MDICAL PHYSICIST; MEDICAL TECHNOLOGY; PARAMEDICAL PERSONNEL; PROSTATE CANCER; RADIATION ONCOLOGIST; RADIATION THERAPIST; STEREOTACTIC BODY RADIATION THERAPY;

EID: 84892453063     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyt161     Document Type: Article

References (20)

1. Kam MK, Leung SF, Zee B, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007;25:4873-9.
2. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070-6.
3. Cahlon O, Hunt M, Zelefsky MJ. Intensity-modulated radiation therapy: supportive data for prostate cancer. Semin Radiat Oncol 2008;18:48-57.
4. Nguyen PL, Gu X, Lipsitz SR, et al. Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol 2011;29:1517-24.
5. Guadagnolo BA, Liu CC, Cormier JN, et al. Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: socioeconomic disparity and geographic variation in a large population-based cohort. Cancer 2010;116:3505-12.
6. Pan H, Simpson DR, Mell LK, et al. A survey of stereotactic body radiotherapy use in the United States. Cancer 2011;117:4566-72.
7. Eisbruch A, Kim HM, Terrell JE, et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:695-704.
8. Chao KS, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001;49:907-16.
9. Mayles WP. Survey of the availability and use of advanced radiotherapy technology in the UK. Clin Oncol (R Coll Radiol) 2010;22:636-42.
10. Herman JM, Thomas CR, Jr. RTOG 0529: intensity modulated radiation therapy and anal cancer, a step in the right direction? Int J Radiat Oncol Biol Phys 2013;86:8-10.
11. Hartford AC, Galvin JM, Beyer DC, et al. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for intensity-modulated radiation therapy (IMRT). Am J Clin Oncol 2012;35:612-7.
12. MacKay RI, Staffurth J, Poynter A, et al. UK guidelines for the safe delivery of intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol) 2010;22:629-35.
13. Routsis D, Staffurth J, Beardmore C, et al. Education and training for intensity-modulated radiotherapy in the UK. Clin Oncol (R Coll Radiol) 2010;22:675-80.
14. Rosenthal DI, Asper JA, Barker JL, Jr, et al. Importance of patient examination to clinical quality assurance in head and neck radiation oncology. Head Neck 2006;28:967-73.
15. Timmerman RD, Kavanagh BD, Cho LC, et al. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 2007;25:947-52.
16. Lefresne S, Olivotto IA, Joe H, et al. Impact of quality assurance rounds in a Canadian radiation therapy department. Int J Radiat Oncol Biol Phys 2013;85:e117-21.
17. The Royal College of Radiologists. Towards Safer Radiotherapy, 2008.
18. International Atomic Energy Agency Vienna. Comprehensive audits of radiotherapy practices: a tool for quality improvement. Quality assurance team for radiation oncology (QUATRO). Vienna, 2007.
19. QA/QC committee of radiotherapy. Final report of proposal to establishment of safety management system to avoid medical error of radiotherapy, 2005.
20. Kutcher GJ, Coia L, Gillin M, et al. Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40. Med Phys 1994;21:581-618.